These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9260236)

  • 1. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
    Bagga A; Sharma A; Srivastava RN
    Pediatr Nephrol; 1997 Aug; 11(4):415-7. PubMed ID: 9260236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
    Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S
    Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study.
    Banerjee S; Sengupta J; Sinha R; Chatterjee S; Sarkar S; Akhtar S; Saha R; Pahari A
    Pediatr Nephrol; 2024 Oct; 39(10):2969-2977. PubMed ID: 38822220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F; Ahmed TM; Samina U
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
    BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
    Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
    Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
    Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO; Kari JA
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
    Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J; Kryński J
    Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS; Shien CY; Chi CS
    Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.
    Dayal U; Dayal AK; Shastry JC; Raghupathy P
    Nephron; 1994; 66(4):408-12. PubMed ID: 8015643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A; Puraswani M; Kalaivani M; Goyal P; Hari P; Bagga A
    Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.